the prospective controlled phase iii clinical trial compared the therapeutic value of the cis-platinum - adriamycin - cyclophosphamide combination ( cap ) and that of the combination of cyclophosphamide , methotrexate , 5-fluorouracil , vincristine , and prednisolone ( cmfvp ) in untreated metastatic breast cancer .
C0042679
vincristine
C0055987
cmfvp